Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 17, Issue 3, Pages 245-256
Publisher
Informa UK Limited
Online
2017-01-17
DOI
10.1080/14737159.2017.1283219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
- (2016) Giuseppe Curigliano et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study
- (2016) Daniel J. Lenihan et al. JOURNAL OF CARDIAC FAILURE
- Curing Cancer, Saving the Heart: A Challenge That Cardioncology Should Not Miss
- (2016) Daniela Cardinale et al. Current Cardiology Reports
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity
- (2015) Eric S. Christenson et al. CLINICAL BIOCHEMISTRY
- Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab
- (2015) M. Putt et al. CLINICAL CHEMISTRY
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chemotherapy-Induced Cardiotoxicity: Detection, Prevention, and Management
- (2014) Judy Truong et al. CANADIAN JOURNAL OF CARDIOLOGY
- Protective effects of spironolactone against anthracycline-induced cardiomyopathy
- (2014) Mahmut Akpek et al. EUROPEAN JOURNAL OF HEART FAILURE
- Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
- (2014) Joerg Herrmann et al. MAYO CLINIC PROCEEDINGS
- Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2014) J. C. Plana et al. European Heart Journal-Cardiovascular Imaging
- Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist
- (2013) Cristian Mornoş et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Cardiac toxicity in cancer survivors
- (2013) Daniel J. Lenihan et al. CANCER
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
- (2013) Bonnie Ky et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Strategies to Prevent and Treat Cardiovascular Risk in Cancer Patients
- (2013) Daniela Cardinale et al. SEMINARS IN ONCOLOGY
- Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease
- (2013) Brandon C. Drafts et al. JACC-Cardiovascular Imaging
- Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate
- (2013) Mariele Dessì et al. SpringerPlus
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
- (2012) G. Curigliano et al. ANNALS OF ONCOLOGY
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
- (2012) Heloisa Sawaya et al. Circulation-Cardiovascular Imaging
- Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
- (2012) Mehmet G. Kaya et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Third Universal Definition of Myocardial Infarction
- (2012) Kristian Thygesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anthracycline-Induced Cardiotoxicity: Cardiac Monitoring by Continuous Wave-Doppler Ultrasound Cardiac Output Monitoring and Correlation to Echocardiography
- (2012) Sandra Geiger et al. ONKOLOGIE
- Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study
- (2012) A. M. C. Mavinkurve-Groothuis et al. European Heart Journal-Cardiovascular Imaging
- Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
- (2011) Heloisa Sawaya et al. AMERICAN JOURNAL OF CARDIOLOGY
- Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients
- (2011) S Romano et al. BRITISH JOURNAL OF CANCER
- Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib
- (2011) P. G. Morris et al. CLINICAL CANCER RESEARCH
- Role of biomarkers in cardioncology
- (2011) Daniela Cardinale et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment
- (2010) Christian Cadeddu et al. AMERICAN HEART JOURNAL
- Recommendations for the use of cardiac troponin measurement in acute cardiac care
- (2010) K. Thygesen et al. EUROPEAN HEART JOURNAL
- Frequency and management of troponin I elevation in patients treated with molecular targeted therapies in phase I trials
- (2010) Stephane Ederhy et al. INVESTIGATIONAL NEW DRUGS
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
- (2010) Daniela Cardinale et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
- (2010) Steven E Lipshultz et al. LANCET ONCOLOGY
- Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays
- (2009) Tobias Reichlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines
- (2009) Annelies M.C. Mavinkurve-Groothuis et al. PEDIATRIC BLOOD & CANCER
- Clinical Correlation between Brain Natriutetic Peptide and Anthracyclin-induced Cardiac Toxicity
- (2009) Ho Sup Lee et al. Cancer Research and Treatment
- Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity
- (2008) J. M. Horacek et al. ANNALS OF ONCOLOGY
- Cardiovascular risk in long-term survivors of testicular cancer
- (2008) David J. Vaughn et al. CANCER
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Simultaneous hemodynamic and serological cardiotoxicity monitoring during immunotherapy with trastuzumab
- (2007) K. Knobloch et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started